The Native Antigen Company

The Native Antigen Company Introduces New Range of Influenza Antigens

Oxford, UK, 16 November 2022: The Native Antigen Company (part of LGC Clinical Diagnostics), one of the worldís leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphereís 2023 flu season. The...
The Native Antigen Company LGC Unit 3 Oxford Technology Park Kidlington OX5 1GN

+44 (0)1865 595230